Overview of Dr. Peled
Dr. Jonathan Peled is an oncologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. He received his medical degree from Albert Einstein College of Medicine of Yeshiva University and has been in practice 7 years. He is one of 494 doctors at Memorial Sloan Kettering Cancer Center who specialize in Oncology. He has more than 90 publications and over 500 citings.
Office
1275 York Ave
New York, NY 10065
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2013 - 2017
- Massachusetts General HospitalResidency, Internal Medicine, 2010 - 2013
- Albert Einstein College of MedicineClass of 2010
Certifications & Licensure
- NY State Medical License 2013 - 2026
- NJ State Medical License 2019 - 2025
- MA State Medical License Active through 2013
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 52 citationsMinimal residual disease negativity in multiple myeloma is associated with intestinal microbiota composition.Matthew J. Pianko, Sean M. Devlin, Eric R. Littmann, Aisara Chansakul, Donna Mastey
Blood Advances. 2019-07-09 - 72 citationsThe Microbiome and Hematopoietic Cell Transplantation: Past, Present, and FutureTessa M. Andermann, Jonathan U. Peled, Christine M. Ho, Pavan Reddy, Marcie L. Riches
Biology of Blood and Marrow Transplantation. 2018-02-19 - 41 citationsFecal microbiota diversity disruption and clinical outcomes after auto-HCT: a multicenter observational studyNiloufer Khan, Sarah Lindner, Antonio L.C. Gomes, Sean M. Devlin, Gunjan L. Shah
Blood. 2021-03-18
Journal Articles
- Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell TransplantationJonathan Peled, MD, The New England Journal of Medicine
Abstracts/Posters
- Antibiotic Exposures and Dietary Intakes Are Associated with Changes in Microbiota Compositions in Allogeneic Hematopoietic Stem Cell Transplant PatientsJonathan U. Peled, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- The Blood Microbiome Predicts Acute Graft-Versus-Host Disease after Stem Cell TransplantationJonathan U. Peled, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Pre-Transplant Fecal Microbial Diversity Independently Predicts Critical Illness after Hematopoietic Cell TransplantationJonathan U. Peled, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Lectures
- Inferior survival after microbiota injury: A multicenter allo-HCT study.2019 ASCO Annual Meeting - 6/1/2019
- Dysgeusia Is Associated with Higher Melphalan Pharmacokinetic Levels and Results in Poorer Caloric Intake and Worse Symptom Burden after Autologous Stem Cell Transplan...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
- The Gut Microbiome and Cancer: MSK Researchers Present New FindingsApril 19th, 2023
- Your Gut Microbes Can Help Fight Cancer, New Research RevealsSeptember 27th, 2022
- ASCO 2021 Research Roundup: Focus on ImmunotherapyJune 7th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: